作者: Mark R Benfield
DOI: 10.1016/S0031-3955(03)00122-6
关键词:
摘要: Pediatric transplantation has seen remarkable advances over the past two decades with reduced morbidity and mortality, rejection rates, improved long-term patient allograft survival. Infants currently have short-term survival rates better than any other age group; in CD recipients are equal to those LD recipients. With decreased rejection, is improving dramatically. Transplantation allows for much risks metabolic status, growth development, more normal social interactions. The future of continues be exciting, opportunities immunosuppressive medications their side effects, elusive goal tolerance seems within reach.